Characterization of retinal disease progression in a 1-year longitudinal study of eyes with mild nonproliferative retinopathy in diabetes type 2

Investigative Ophthalmology and Visual Science

Volumn 56, Issue 9, 2015, Pages 5698-5705

  Ribeiro, Luisa ^a   Bandello, Francesco ^b   Tejerina, Amparo Navea ^c   Vujosevic, Stela ^d   Varano, Monica ^e   Egan, Catherine ^f   Sivaprasad, Sobha ^g   Menon, Geeta ^h   Massin, Pascale ⁱ   Verbraak, Frank D ^j   Lund Andersen, Henrik ^k   Martinez, Jose P ^l   Jürgens, Ignasi ^m   Smets, Erica ⁿ   Coriat, Caroline ^o   Wiedemann, Peter ^p   Àgoas, Victor ^q   Querques, Giuseppe ^r   Holz, Frank G ^s   Nunes, Sandrina ^a   Neves, Catarina ^a   Cunha Vaz, José ^a   more..

^a ASSOCIATION FOR INNOVATION AND BIOMEDICAL RESEARCH ON LIGHT AND IMAGE AIBILI   (Portugal)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^c Centre for Public Health Research Fundacion para la Invest Sanitaria y Biomedica   (Spain)

^d UNIVERSITY OF PADOVA   (Italy)

^e IRCCS FONDAZIONE BIETTI   (Italy)

^f MOORFIELDS EYE HOSPITAL   (United Kingdom)

^g KING'S COLLEGE LONDON   (United Kingdom)

^h FRIMLEY PARK HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

ⁱ HÔPITAL LARIBOISIÈRE   (France)

^j ACADEMIC MEDICAL CENTER   (Netherlands)

^k UNIVERSITY OF COPENHAGEN   (Denmark)

^l ROTTERDAM EYE HOSPITAL   (Netherlands)

^m Institut Català de Retina ICR   (Spain)

ⁿ ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^o CENTRE HOSPITALIER NATIONAL D OPHTALMOLOGIE DES QUINZE VINGTS   (France)

^p UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^q Instituto de Oftalmologia Dr Gama Pinto   (Portugal)

^r CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

^s UNIVERSITY OF BONN   (Germany)

more..

Author keywords

Biomarkers; Diabetes type 2; Diabetic retinopathy; Macular edema; Microaneurysms

Indexed keywords

ADULT; ARTICLE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; DIABETIC MACULAR EDEMA; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MICROANEURYSM; MIDDLE AGED; MULTICENTER STUDY; OBSERVATIONAL STUDY; OPHTHALMOSCOPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETINA DISEASE; RETINAL THICKNESS; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; VISUAL ACUITY; VISUAL SYSTEM PARAMETERS; CLINICAL TRIAL; COMPLICATION; CONTROLLED STUDY; FOLLOW UP; NON INSULIN DEPENDENT DIABETES MELLITUS; OPTICAL COHERENCE TOMOGRAPHY; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RETINA; TIME;

DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RETINA; TIME FACTORS; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY;

EID: 84940705940     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.15-16708     Document Type: Article

References (18)

1. Fong DS, Aiello L, Gardner TW, et al. Retinopathy in diabetes. Diabetes Care. 2004;27(suppl 1):S84–S87
2. Sinclair AJ, Bayer AJ, Girling AJ, Woodhouse KW. Older adults, diabetes mellitus and visual acuity: a community-based casecontrol study. Age Ageing. 2000;29:335–339
3. Nunes S, Ribeiro L, Lobo C, Cunha-Vaz J. Three different phenotypes of mild nonproliferative diabetic retinopathy with different risks for development of clinically significant macular edema. Invest Ophthalmol Vis Sci. 2013;54:4595–4604
4. Aiello LP, Vignati L, Sheetz MJ, et al. Oral protein kinase c b inhibition using ruboxistaurin: efficacy, safety, and causes of vision loss among 813 patients (1,392 eyes) with diabetic retinopathy in the Protein Kinase C b Inhibitor-Diabetic Retinopathy Study and the Protein Kinase C b Inhibitor- Diabetic Retinopathy Study 2. Retina. 2011;31:2084–2094
5. Cunha-Vaz J, Martinho C. Developing an international network for clinical research in ophthalmology: the European Vision Institute Clinical Research Network (EVICR.net). Clin Investig (Lond). 2011;1:375–380
6. EVICR: European Network of Clinical Research in Ophthalmology Information Update - November 2012. Ophthalmologica. 2014;231:180–184
7. Grading diabetic retinopathy from stereoscopic color fundus photographs—an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology. 1991;98(5 suppl):786–806
8. Treatment techniques and clinical guidelines for photocoagulation of diabetic macular edema. Early Treatment Diabetic Retinopathy Study Report Number 2. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology. 1987;94: 761–774
9. Bernardes R, Nunes S, Pereira I, et al. Computer-assisted microaneurysm turnover in the early stages of diabetic retinopathy. Ophthalmologica. 2009;223:284–291
10. Ribeiro ML, Nunes S, Cunha-Vaz J. Microaneurysm turnover at the macula predicts risk of development of clinically significant macular edema in persons with mild nonproliferative diabetic retinopathy. Diabetes Care. 2013;36:1254–1259
11. Haritoglou C, Kernt M, Neubauer A, et al. Microaneurysm formation rate as a predictive marker for progression to clinically significant macular edema in nonproliferative diabetic retinopathy. Retina. 2014;34:157–164
12. Nunes S, Pires I, Rosa A, Duarte L, Bernardes R, Cunha-Vaz J. Microaneurysm turnover is a biomarker for diabetic retinopathy progression to clinically significant macular edema: findings for type 2 diabetics with nonproliferative retinopathy. Ophthalmologica. 2009;223:292–297
13. Chalam KV, Bressler SB, Edwards AR, et al. Retinal thickness in people with diabetes and minimal or no diabetic retinopathy: Heidelberg Spectralis optical coherence tomography. Invest Ophthalmol Vis Sci. 2012;53:8154–8161
14. Bressler NM, Miller KM, Beck RW, et al. Observational study of subclinical diabetic macular edema. Eye (Lond). 2012;26:833–840
15. Browning DJ, Fraser CM. The predictive value of patient and eye characteristics on the course of subclinical diabetic macular edema. Am J Ophthalmol. 2008;145:149–154
16. Pires I, Santos AR, Nunes S, Lobo C, Cunha-Vaz J. Subclinical macular edema as a predictor of progression to clinically significant macular edema in type 2 diabetes. Ophthalmologica. 2013;230:201–206
17. Asefzadeh B, Fisch BM, Parenteau CE, Cavallerano AA. Macular thickness and systemic markers for diabetes in individuals with no or mild diabetic retinopathy. Clin Experiment Ophthalmol. 2008;36:455–463
18. Van Dijk HW, Kok PHB, Garvin M, et al. Selective loss of inner retinal layer thickness in type 1 diabetic patients with minimal diabetic retinopathy. Invest Ophthalmol Vis Sci. 2009;50: 3404–3409.